IN FOCUS FEATURE
A-B Tech Grows Biotech in Asheville
FROM OUR WEB SITE
In Focus
Small Business Incubator Contributes to Biotechnology Growth in Asheville
Low-cost space to conduct research is just one of the things that start-up biotechnology companies need to succeed.
Asheville-Buncombe Technical Community College created 30,000 square feet of that space. But it also took the company incubation process one step further and created the Small Business Incubator program. The two-year program helps small businesses expand into the surrounding community. One of those businesses plans to manufacture an algae-based alternative fuel.
Read more about the incubator in this week's In Focus.
From Our Web Site
Affinergy Receives $3.6M in Federal Grants
The Duke University spinout will use the grants to further develop its proprietary medical device delivery technology.
Argos Opens New Cancer Trial
Durham's Argos Therapeutics began a Phase 2a clinical trial combining its personalized anti-cancer approach with standard medicine to treat advanced renal-cell carcinoma.
STI, UNC-C Sign Ideas Pact
Southeast TechInventures and UNC Charlotte have penned an agreement aimed at streamlining technology transfer.
WFU Gets $9.3M from NIH
Wake Forest University researchers won a $9.3 million, four-year extension to a long-running NIH blood lipids study.
NC A&T Wins $18.5M NSF Grant
North Carolina A&T State University is one of a select group of universities nationwide, and the first historically black institution ever, chosen to lead a prestigious National Science Foundation Engineering Research Center.
UNC Spinoff Lands $2M Grant
Morphormics has won a $2 million federal grant to help it commercialize its medical technology.
ADHD Drug Performs Well, Testing Shows
Durham's Addrenex, developers of an experimental drug designed to treat attention-deficit hyperactivity disorder in children, helped improve ADHD symptoms in a study. The drug produced no significant side effects.
From the (Raleigh) News & Observer
Gaston College President Tapped for Regional Award
Patricia Skinner was chosen as the recipient of the 2008 Southern Regional Chief Executive Officer Award.
From the Lincoln-Tribune
Researcher Studies Critical Protein at ECU
A researcher at ECU is studying a protein that might hold a key to reducing high blood pressure and improving kidney function in people with kidney disease.
From the (Greenville) Daily Reflector
- Thomas Staab, II, CFO and treasurer of Durham-based Inspire Pharmaceuticals, has been promoted to executive vice president. Benjamin Yerxa, Ph.D., chief scientific officer and executive vice president of strategic operations, has been promoted to executive vice president and chief, research and development.
- Metabolon, a Research Triangle Park-based firm specializing in metabolomics-driven biomarker discovery and analysis, has appointed Edward Erickson to its board of directors. Erickson is a board member, advisor and consultant to several other life-science companies and venture-capital firms. He has served as president, CEO or director of more than a dozen medical products companies, four of which successfully completed initial public offerings of stock during his tenure.
Please send Community Watch items to Jim Shamp.
October 22
NC Marine Biotech Forum
(Wilmington)
October 28
Charlotte Biotechnology Conference
(Charlotte)
December 4-5
SE BIO Investor Forum
(Palm Beach, Fla.)
February 16-17
Biotech 2009
(Raleigh)
May 18-21
BIO International Convention
(Atlanta)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, September 11, 2008. For the latest headlines from North Carolina's biotechnology industry, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.